In a bold move, consumer products giant Kimberly-Clark has agreed to a $40 billion deal to acquire Kenvue, the manufacturer of the iconic pain reliever Tylenol. The acquisition signals Kimberly-Clark's confidence in the long-term prospects of the brand, despite recent controversies surrounding the product's safety. Tylenol, a household name for...